Abstract: In some examples, a system receives a user interface (UI) context of a UI, the UI context identifying a relationship between UI elements of the UI, and translates, based on the identified relationship between the UI elements in the UI context, text in the UI from a first language to a second language.

Abstract: Disclosed are applications of a mussel adhesive protein or preparations thereof in treatment and prevention of diseases related to melanin. Specifically disclosed are applications of a mussel adhesive protein or preparations thereof in treatment and prevention of pigmentations such as chloasma, freckles, melanosis, applications in skin cancers represented by melanoma, and applications in treatment of pigmentation possibly caused by skin diseases or drugs.

Abstract: A synchronous belt drive system having: a synchronous belt with a tensile cord of high-modulus fiber such as glass, carbon, PBO, or aramid; a driver sprocket and at least one driven sprocket, at least one of which is an obround sprocket; and a tensioner having: a base having a cylindrical portion extending axially with a radially outer surface and a receiving portion, an eccentric arm pivotally engaged with the radially outer surface, a torsion spring disposed within the receiving portion, the torsion spring applying a biasing force to the eccentric arm, and a pulley journalled to the eccentric arm. Preferably, no one of the eccentric arm, pulley, or torsion spring is axially displaced along an axis A-A from the others. The obround sprocket has a toothed surface and at least one linear portion disposed between two arcuate portions having a constant radius, the linear portion having a predetermined length.

Abstract: The present invention discloses a method for real-time positioning of a smart device, comprising: getting tri-axial acceleration sequences truncated in turn by using a preset time period in the world coordinate individually; acquiring a dominate frequency fstep by applying fast Fourier transform (FFT) on the truncated Z-axis acceleration sequence, using a band-pass filter with a pass band [fstep?0.5 Hz, fstep+0.5 Hz] to filter the truncated tri axial acceleration sequences individually; comparing the time domain waveform form from the filtered Z-axis acceleration sequence with a preset step threshold, and counting each peak above the threshold as a step to acquire a user's step number in the present time period; determining the moving direction of the smart device in the time period by calculating the filtered X-axis and Y-axis acceleration sequences; determining the current position of the smart device by calculating the user's step number and the moving direction of the smart device.

Abstract: The invention relates to a mussel adhesive protein (MAP) and an application thereof in inhibiting catarrh, and specifically, to applications of a MAP or a product thereof in oral mucositis, rhinitis, otitis media, pharyngitis, laryngitis, bronchitis, esophagitis, gastritis, enteritis, cervicitis, endomyometritis, inflammation resulting from inhalation injury, and oral cavity cancer, nasopharyngeal cancer, carcinoma of middle ear, conjunctival cancer, laryngeal cancer, lung cancer, esophageal cancer, stomach cancer, bowel cancer, cervical cancer, endometrial cancer, and other cancers resulting from the inflammation. The MAP can inhibit symptoms such as flush, fever, swell, and pain owing to catarrh, facilitating healing, relieving itch and pain, and having broad applications in the fields of medicines, cosmetics, medical products, disinfection products, healthcare products, foods, and household goods.

Abstract: Disclosed are applications of a mussel adhesive protein or preparations thereof in suppression of skin inflammations. Specifically disclosed are applications of a mussel adhesive protein, preparations thereof and applications thereof in dermatitis, eczema, skin ulcer, technologies related to burns (comprising skin grafting), perniones, surgical incisions, herpes, abrasions, scars, psoriasis, erythema multiforme, skin damage after radiotherapy, skin cancers, folliculitis, urticaria and drug eruption, and applications in sunburn, polymorphous light eruption, pathological alopecia (comprising hair transplant), acne vulgaris, rosacea (that is, acne rosacea), and the like, and applications in the treatment of otitis externa.

Abstract: The present invention provides antibodies and antigen-binding fragments thereof that specifically bind to cells expressing acid-sensing ion channel-1 (ASIC1). According to certain embodiments of the invention, the antibodies inhibit acid-induced, ASIC1-mediated ion currents in cells expressing human ASIC1. The antibodies of the invention are useful for the treatment of pain, including pain associated with surgical intervention and various diseases and disorders.

Abstract: The invention relates to a mussel adhesive protein (MAP) and an application thereof in inhibiting catarrh, and specifically, to applications of a MAP or a product thereof in oral mucositis, rhinitis, otitis media, pharyngitis, laryngitis, bronchitis, esophagitis, gastritis, enteritis, cervicitis, endomyometritis, inflammation resulting from inhalation injury, and oral cavity cancer, nasopharyngeal cancer, carcinoma of middle ear, conjunctival cancer, laryngeal cancer, lung cancer, esophageal cancer, stomach cancer, bowel cancer, cervical cancer, endometrial cancer, and other cancers resulting from the inflammation. The MAP can inhibit symptoms such as flush, fever, swell, and pain owing to catarrh, facilitating healing, relieving itch and pain, and having broad applications in the fields of medicines, cosmetics, medical products, disinfection products, healthcare products, foods, and household goods.

Abstract: In one embodiment, a method selects a first reference block in a first reference frame and a second reference block in a second reference frame. The first reference block and the second reference block are used to predict a current block in a current frame. A first region is selected based on the first reference block, a second region is selected based the second reference block, and a third region is selected based on the current block. The method compares a characteristic of the first region to a characteristic of the third region and compares a characteristic of the second region to the characteristic of the third region to adaptively determine a first weight for the first reference block and a second weight for the second reference block. Then, a prediction block is calculated for the current block using the first weight and the second weight.

Abstract: In one embodiment, a method determines if a first flag for using a most probable mode (MPM) set for intra prediction is set. When the first flag indicates the MPM set is used, the method decodes a first index for the MPM, the first index indicating a first intra prediction mode in the MPM set. When the first flag does not indicate the MPM set is being used, the method determines if a second flag for using a near-MPM set is set. When the second flag indicates the near-MPM set is being used, the method decodes a second index for the near-MPM, the second index indicating a second intra prediction mode in the near-MPM set. When the second flag does not indicate the near-MPM is being used, the method decodes a third index for a non-MPM, the third index indicating a third intra prediction mode in the non-MPM set.

Abstract: A method includes transcoding a first block of a video. The first block is associated with a first block tree pattern defining a structure of splitting a block into smaller blocks. A bit string of bits for the first block tree pattern is included in an encoded bitstream for the video. The method determines that the first block tree pattern of the first block can be reused for a second block tree pattern of a second block and includes information in the encoded bitstream that indicates that the first block tree pattern is to be used to decode the second block from the encoded bitstream.

Abstract: In one embodiment, a method selects a first reference block in a first reference frame and a second reference block in a second reference frame. The first reference block and the second reference block are used to predict a current block. The first reference block is selected as an anchor point. Then, the method searches in the second reference frame for a third reference block and determines whether the third reference block is a better reference block than the second reference block for predicting the current block.

Abstract: A cover fabric for a power transmission belt, the fabric woven from warp yarns and weft yarns; the warp yarns and weft yarns each plied from a first filament yarn and a second filament yarn; the first filament yarn comprising higher tensile strength fibers than the second filament yarn; and the fabric woven in a modified twill pattern. A toothed belt with the cover fabric on the teeth, oriented on a bias, with the fabric having a bias angle less than 90°.

Abstract: A toothed power transmission belt with a smooth back side surface has a back jacket on the back side surface; wherein the back jacket comprises a closed-mesh, knit fabric tube. The fabric tube may be knitted on a circular weft knitting machine and may be heat set after knitting. The fabric tube may be treated with an epoxy, RFL or other treatment to provide for oil resistance, adhesion, frictional properties, etc.

Abstract: A method of making weaving a tubular fabric of particular usefulness in power transmission belting and other technical applications. The method includes weaving a secondary, removable warp yarn along with the primary warp yarn in the region of the edge folds on a shuttle loom. The removable warp yarn may be a soluble or meltable yarn. The removable yarn is removed after weaving, resulting in substantially uniform warp density all around the tubular fabric.

Abstract: The present invention provides antibodies that bind specifically to TrkB and methods of using the same. According to certain embodiments, the antibodies of the invention are agonist antibodies that are neuroprotective, as shown by their effect on enhancing the survival of retinal ganglion cells in vitro. As such, these agonist antibodies may be used to treat diseases or disorders of the eye, such as, but not limited to glaucoma. In addition, other neuronal diseases or disorders may benefit from treatment with these agonist antibodies, including any disease or disorder characterized in part by neuronal damage. In certain embodiments, the invention includes antibodies that bind TrkB and mediate cell signaling. The antibodies of the invention may be fully human, non-naturally occurring antibodies.

Abstract: Non-human animal genomes, non-human animal cells, and non-human animals comprising a humanized TRKB locus and methods of making and using such non-human animal genomes, non-human animal cells, and non-human animals are provided. Non-human animal cells or non-human animals comprising a humanized TRKB locus express a human TRKB protein or a chimeric transthyretin protein, fragments of which are from human TRKB. Methods are provided for using such non-human animals comprising a humanized TRKB locus to assess in vivo efficacy of human-TRKB-targeting reagents such as nuclease agents designed to target human TRKB.

Abstract: The invention relates to a mussel adhesive protein (MAP) and an application thereof in inhibiting catarrh, and specifically, to applications of a MAP or a product thereof in oral mucositis, rhinitis, otitis media, pharyngitis, laryngitis, bronchitis, esophagitis, gastritis, enteritis, cervicitis, endomyometritis, inflammation resulting from inhalation injury, and oral cavity cancer, nasopharyngeal cancer, carcinoma of middle ear, conjunctival cancer, laryngeal cancer, lung cancer, esophageal cancer, stomach cancer, bowel cancer, cervical cancer, endometrial cancer, and other cancers resulting from the inflammation. The MAP can inhibit symptoms such as flush, fever, swell, and pain owing to catarrh, facilitating healing, relieving itch and pain, and having broad applications in the fields of medicines, cosmetics, medical products, disinfection products, healthcare products, foods, and household goods.

Abstract: Disclosed are applications of a mussel adhesive protein or preparations thereof in suppression of skin inflammations. Specifically disclosed are applications of a mussel adhesive protein, preparations thereof and applications thereof in dermatitis, eczema, skin ulcer, technologies related to burns (comprising skin grafting), perniones, surgical incisions, herpes, abrasions, scars, psoriasis, erythema multiforme, skin damage after radiotherapy, skin cancers, folliculitis, urticaria and drug eruption, and applications in sunburn, polymorphous light eruption, pathological alopecia (comprising hair transplant), acne vulgaris, rosacea (that is, acne rosacea), and the like, and applications in the treatment of otitis externa.

Abstract: Disclosed are applications of a mussel adhesive protein or preparations thereof in treatment and prevention of diseases related to melanin. Specifically disclosed are applications of a mussel adhesive protein or preparations thereof in treatment and prevention of pigmentations such as chloasma, freckles, melanosis, applications in skin cancers represented by melanoma, and applications in treatment of pigmentation possibly caused by skin diseases or drugs.